CYLD expression in endometrial carcinoma and correlation with clinicohistopathological parameters-Reference-Cited by-同舟云学术

CYLD expression in endometrial carcinoma and correlation with clinicohistopathological parameters

Published:2022-07 Issue:4 Volume:61 Page:596-600
ISSN:1028-4559
Container-title:Taiwanese Journal of Obstetrics and Gynecology
language:en
Short-container-title:Taiwanese Journal of Obstetrics and Gynecology

Author:

Papadatou Vasiliki,Tologkos Stylianos,Tsolou Avgi^ORCID,Deftereou Theodora-Eleftheria,Liberis Anastasios,Trypsianis Grigorios,Alexiadis Triantafyllos,Georgiadi Kyriaki,Alexiadi Christina-Angelika,Nikolaidou Christina,Lambropoulou Maria

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference36 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J Clin,2018

2. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018;Ferlay;Eur J Cancer,2018

3. Cancer statistics, 2018;Siegel;CA A Cancer J Clin,2018

4. Cancer statistics, 2020;Siegel;CA A Cancer J Clin,2020

5. Cancer statistics, 2017;Siegel;CA A Cancer J Clin,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating molecular pathology to endometrial cancer;Taiwanese Journal of Obstetrics and Gynecology;2023-11

2. CYLD in health and disease;Disease Models & Mechanisms;2023-06-01

3. Switch from morphology-based pathology to molecular-based pathology: Time is up;Taiwanese Journal of Obstetrics and Gynecology;2023-01

4. Endometrial cancer: Part I. Basic concept;Taiwanese Journal of Obstetrics and Gynecology;2022-11

5. Molecular pathology and prognosis of endometrial cancer;Taiwanese Journal of Obstetrics and Gynecology;2022-11